Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116273542 | 11627354 | 2 | F | 20151005 | 20151013 | 20160922 | PER | US-AMGEN-USASL2015013230 | AMGEN | 54.00 | YR | A | M | Y | 0.00000 | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116273542 | 11627354 | 1 | PS | NEUPOGEN | FILGRASTIM | 1 | Subcutaneous | 480 MG, UNK | U | 103353 | 480 | MG | UNKNOWN FORMULATION | ||||||
| 116273542 | 11627354 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 400 MG, 1 IN 2 WK | 0 | 400 | MG | QOW | |||||||
| 116273542 | 11627354 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, UNK | 0 | 600 | MG | ||||||||
| 116273542 | 11627354 | 4 | SS | KYTRIL | GRANISETRON HYDROCHLORIDE | 1 | Unknown | 2 MG, UNK | 0 | 2 | MG | INJECTION | |||||||
| 116273542 | 11627354 | 5 | SS | KYTRIL | GRANISETRON HYDROCHLORIDE | 1 | Unknown | 1 MG, UNK | 0 | 1 | MG | INJECTION | |||||||
| 116273542 | 11627354 | 6 | C | EPOETIN ALFA | ERYTHROPOIETIN | 1 | Subcutaneous | 40000 UNIT, UNK | 0 | UNKNOWN FORMULATION | |||||||||
| 116273542 | 11627354 | 7 | C | EPOETIN ALFA | ERYTHROPOIETIN | 1 | Subcutaneous | 40000 UNIT, UNK | 0 | UNKNOWN FORMULATION | |||||||||
| 116273542 | 11627354 | 8 | C | ARANESP | DARBEPOETIN ALFA | 1 | 500 MCG, UNK | 0 | 500 | UG | UNKNOWN FORMULATION | ||||||||
| 116273542 | 11627354 | 9 | C | ATIVAN | LORAZEPAM | 1 | 1 MG, UNK | 0 | 1 | MG | |||||||||
| 116273542 | 11627354 | 10 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 250 MCG, UNK | 0 | 250 | UG | ||||||||
| 116273542 | 11627354 | 11 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 250 MCG, UNK | 0 | 250 | UG | ||||||||
| 116273542 | 11627354 | 12 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 250 MCG, UNK | 0 | 250 | UG | ||||||||
| 116273542 | 11627354 | 13 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 250 MCG, UNK | 0 | 250 | UG | ||||||||
| 116273542 | 11627354 | 14 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | IN 50 CC NS (10 MG), UNK | 0 | 10 | MG | ||||||||
| 116273542 | 11627354 | 15 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Subcutaneous | 1000 MCG, UNK | 0 | 1000 | UG | ||||||||
| 116273542 | 11627354 | 16 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 1000 MCG, UNK | 0 | 1000 | UG | ||||||||
| 116273542 | 11627354 | 17 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 1000 MCG, UNK | 0 | 1000 | UG | ||||||||
| 116273542 | 11627354 | 18 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 1000 MCG, UNK | 0 | 1000 | UG | ||||||||
| 116273542 | 11627354 | 19 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Subcutaneous | 1000 UNK, UNK | 0 | ||||||||||
| 116273542 | 11627354 | 20 | C | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous drip | IN 250 CC NS (400 MG), UNK | 0 | 400 | MG | ||||||||
| 116273542 | 11627354 | 21 | C | AMOXICILLIN. | AMOXICILLIN | 1 | UNK | 0 | |||||||||||
| 116273542 | 11627354 | 22 | C | MANNITOL. | MANNITOL | 1 | Intravenous (not otherwise specified) | 50 ML, UNK | 0 | 50 | ML | ||||||||
| 116273542 | 11627354 | 23 | C | LASIX | FUROSEMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 116273542 | 11627354 | 24 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MCG, UNK | 0 | 20 | UG | |||||||||
| 116273542 | 11627354 | 25 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 116273542 | 11627354 | 26 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 116273542 | 11627354 | 27 | C | TYLENOL | ACETAMINOPHEN | 1 | 650 MG, UNK | 0 | 650 | MG | |||||||||
| 116273542 | 11627354 | 28 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, 1 IN 1 D | 0 | 1 | MG | QD | ||||||||
| 116273542 | 11627354 | 29 | C | CISPLATIN. | CISPLATIN | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 116273542 | 11627354 | 30 | C | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous drip | IN 100CC NS (900 MG) | 0 | 900 | MG | ||||||||
| 116273542 | 11627354 | 31 | C | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | IN 100CC NS (900 MG) | 0 | 900 | MG | ||||||||
| 116273542 | 11627354 | 32 | C | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous drip | IN 100CC NS (800 MG) | 0 | 800 | MG | ||||||||
| 116273542 | 11627354 | 33 | C | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous drip | IN 100CC NS (800 MG) | 0 | 800 | MG | ||||||||
| 116273542 | 11627354 | 34 | C | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous drip | IN 100CC NS (900 MG) | 0 | 900 | MG | ||||||||
| 116273542 | 11627354 | 35 | C | ALIMTA | PEMETREXED DISODIUM | 1 | 1000 MG, UNK | 0 | 1000 | MG | |||||||||
| 116273542 | 11627354 | 36 | C | NAVELBINE | VINORELBINE TARTRATE | 1 | UNK | 0 | |||||||||||
| 116273542 | 11627354 | 37 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 4 MG, 2 IN 1 D | 0 | 4 | MG | BID | |||||||
| 116273542 | 11627354 | 38 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116273542 | 11627354 | 1 | Product used for unknown indication |
| 116273542 | 11627354 | 2 | Malignant neoplasm of pleura |
| 116273542 | 11627354 | 3 | Mesothelioma |
| 116273542 | 11627354 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116273542 | 11627354 | Asthenia | |
| 116273542 | 11627354 | Back pain | |
| 116273542 | 11627354 | Balance disorder | |
| 116273542 | 11627354 | Chest pain | |
| 116273542 | 11627354 | Cough | |
| 116273542 | 11627354 | Diarrhoea | |
| 116273542 | 11627354 | Dyspnoea | |
| 116273542 | 11627354 | Fatigue | |
| 116273542 | 11627354 | Headache | |
| 116273542 | 11627354 | Malaise | |
| 116273542 | 11627354 | Nausea | |
| 116273542 | 11627354 | Off label use | |
| 116273542 | 11627354 | Pain in extremity | |
| 116273542 | 11627354 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116273542 | 11627354 | 2 | 20080513 | 0 | ||
| 116273542 | 11627354 | 3 | 20080930 | 0 | ||
| 116273542 | 11627354 | 6 | 20100809 | 20100809 | 0 | |
| 116273542 | 11627354 | 7 | 20110404 | 20110404 | 0 | |
| 116273542 | 11627354 | 10 | 20100601 | 20100601 | 0 | |
| 116273542 | 11627354 | 11 | 20100729 | 20100729 | 0 | |
| 116273542 | 11627354 | 12 | 20110404 | 20110404 | 0 | |
| 116273542 | 11627354 | 13 | 20110428 | 20110428 | 0 | |
| 116273542 | 11627354 | 14 | 20100601 | 20100601 | 0 | |
| 116273542 | 11627354 | 15 | 20100601 | 20100601 | 0 | |
| 116273542 | 11627354 | 16 | 20100729 | 20100729 | 0 | |
| 116273542 | 11627354 | 17 | 20110404 | 20110404 | 0 | |
| 116273542 | 11627354 | 18 | 20110428 | 20110428 | 0 | |
| 116273542 | 11627354 | 19 | 20100819 | 20100819 | 0 | |
| 116273542 | 11627354 | 20 | 20100601 | 20100601 | 0 | |
| 116273542 | 11627354 | 30 | 20100601 | 20100601 | 0 | |
| 116273542 | 11627354 | 31 | 20100729 | 20100729 | 0 | |
| 116273542 | 11627354 | 32 | 20110404 | 20110404 | 0 | |
| 116273542 | 11627354 | 33 | 20110428 | 20110428 | 0 | |
| 116273542 | 11627354 | 34 | 20100819 | 20100819 | 0 |